Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 284-895-5 | CAS number: 84989-06-0 The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Remarks:
- Summary of available data used for the endpoint assessment of the target substance
- Adequacy of study:
- key study
- Justification for type of information:
- refer to analogue justification provided in IUCLID section 13
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- no information on strain used, no information on statistical evaluation given
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- single application by gavage, 5 rats/dose group, 4 doses, undiluted liquid, time of recovery: up to 14 days, observations for signs of toxicity, necropsy at the end of the observation time
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- no data
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- no further data
- Doses:
- 147, 215, 316, 464 mg/kg bw
- No. of animals per sex per dose:
- 5 male rats/dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: daily; weighing at the beginning and at the end
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross autopsy of survivors and decedents - Statistics:
- yes, method not described
- Preliminary study:
- no data
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- ca. 242 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 190 - <= 308
- Mortality:
- see section"remarks on results including tables and figures"
- Clinical signs:
- other: onset: 0-4 hours: hypoactivity, tremor, convulsions, salivation, prostration, death (see section"remarks on results including tables and figures")
- Gross pathology:
- survivors: no significant findings
decedents: inflammation of the gastrointesinal tract, hyperemia of lungs, liver, kidneys
see section"remarks on results including tables and figures" - Other findings:
- no further data
- Interpretation of results:
- other: CLP/EU GHS Category 3 (H301) according to Regulation (EC) No 1272/2008
- Conclusions:
- CLP: Acute tox 3, H 301
- Executive summary:
Single oral application of undiluted testsubstance by gavage to 5 rats/dose group and an observation time up to 14 days resulted in an LD50 value of 242 mg/kg bw.
Dosage mg/kg bw |
Onset of sympt 0-4hrs |
Mortality |
Mortality cumulative |
|||
0-4hrs |
day3 |
day6 |
day7 |
|||
147 |
S |
|
|
|
|
0/5 |
215 |
S |
|
1/5 |
|
1/5 |
2/5 |
316 |
S |
3/5 |
|
1/5 |
|
4/5 |
464 |
S |
4/5 |
1/5 |
|
|
5/5 |
S = signs of intoxication: hypoactivity, tremors, convulsions, salivation, prostration
survivors: recovery within observation time,
gross necropsy: no significant findings
decedents, gross necropsy: inflammation of the gastrointestinal tract,
hyperemia of lungs, liver and kidneys
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No information about strain used, GLP
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- 5 rats/dose group, observed for symptoms for up to 14 d, afterwards gross autopsy
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- no further data
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- no flurther data
- Doses:
- 100, 147, 215, 316 mg/kg bw
- No. of animals per sex per dose:
- 5 male rats/dose
- Control animals:
- no
- Details on study design:
- no further details
- Statistics:
- yes, but method not mentioned
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 207 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 172 - <= 250
- Mortality:
- mortality occurred within 4 hours post dosing
100 mg/kg bw: 0/5; 147 mg/kg bw: 0/5; 215 mg/kg bw: 3/5; 316 mg/kg bw: 5/5 - Clinical signs:
- other: onset in all animals within the first 4 hours post dosing: hypoactivity, tremors, lacrimation, dyspnea, hemorrhagic rhinitis, convulsions, prostration, recovery occurred in all survivors
- Gross pathology:
- Necropsy of the rats that died revealed gastrointestinal inflammation and haemorrhage and hyperaemia of the lungs, liver and kidney.
Survivors showed only gastrointestinal tract inflammation.
- Other findings:
- no further data
- Interpretation of results:
- other: CLP/EU GHS Category 3 (H301) according to Regulation (EC) No 1272/2008
- Conclusions:
- CLP: Acute tox 3, H 301
- Executive summary:
Following single oral doses to rats the LD50 was determined 207 mg/kg bw. The observed signs of intoxication included hypoactivity, tremors, lacrimation, dyspnea, hemorrhagic rhinitis, convulsions and prostration.
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 15 March 2004 to 11 April 2004
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- yes
- Remarks:
- see Principle of method if other than guideline
- Principles of method if other than guideline:
- Deviations:
The dosage, postdosage and scheduled sacrifice periods were each extended for an additional 3 days. 30 rats were received at the testing facility rather than the 20 rats stated in the protocol. Rat 5389 in the 550 mg/kg bw dosage group was given 3 h and 4 h observations at 4 h 39 mins and 4 h 46 mins, respectively. These deviations are not considered to adversely affect the study integrity. - GLP compliance:
- yes
- Remarks:
- Quality assurance statement only.
- Test type:
- up-and-down procedure
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Crl:CD(SD)IGS BR VAF/Plus
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Portage, Michigan, USA
- Age at study initiation: 63 days (at arrival)
- Weight at study initiation: 197 - 223 g (the day after arrival)
- Fasting period before study: Fasted on the night before the dosage administration, with feed returned to the animals following the 4 h clinical observation.
- Housing: Individually housed in stainless-steel wire-bottomed cages.
- Diet (e.g. ad libitum): Certified Rodent Diet #5002 (PMI Nutrition International, Inc., St. Louis, Missouri, USA).
- Water (e.g. ad libitum): Local water, passed through a reverse osmosis membrane, available ad libitum, via individual water bottles. Chlorine was added to the processed water as a bacteriostat.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 64 - 79°F (18 - 26°C)
- Humidity (%): 30 - 70%
- Air changes (per hr): Positive airflow, minimum of 10 changes per hour of HEPA filtered air.
- Photoperiod (hrs dark / hrs light): 12 h dark / 12 h light
IN-LIFE DATES: From: 15 March 2004 To: 11 April 2004 - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 35 mg/mL vehicle, 110 mg/mL vehicle and 350 mg/mL vehicle
- Amount of vehicle (if gavage): 5 mL/kg
- Justification for choice of vehicle: Not stated, guideline vehicle substance.
- Lot/batch no. (if required): 062K0006
- Purity: Not stated - Doses:
- 175, 550 and 1750 mg/kg bw
- No. of animals per sex per dose:
- All females, 1 rat for 175 mg/kg bw, 4 rats for 550 mg/kg bw, 4 rats for 1750 mg/kg bw.
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Pre-dose, at least once in the 30 mins after dosage, approx. hourly intervals for the first 4 h and then daily thereafter for observations. Body weights were recorded weekly during acclimation, daily during the dosing and observation period and at sacrifice.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, feed consumption - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 980.62 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Calculated from log10 values.
- Sex:
- female
- Dose descriptor:
- other: NOEL
- Effect level:
- ca. 175 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Adverse clinical signs at 550 mg/kg bw
- Mortality:
- 3 rats died in the 1750 mg/kg bw dose group from treatment related effects.
- Clinical signs:
- other: Clinical observations which were determined to be dose related included: lacrimation, excess salivation and urine stained fur in both the 550 and 1750 mg/kg bw dose groups. Decreased motor activity, twitches, prostrate, ptosis, limited use of hindlimbs, l
- Gross pathology:
- Necropsy confirmed the clinical observations. No gross lesions were found.
- Other findings:
- Feed consumption values, both absolute (g/day) and relative (g/kg bw/day) showed a dose dependent reduction in the day after dosing in the 550 and 1750 mg/kg bw dose groups. This trend continued until day 5 post dosing, after which the values remaind comparative to the 175 mg/kg bw dosed animal.
- Interpretation of results:
- other: CLP/EU GHS Category 4 (H302) according to Regulation (EC) No 1272/2008
- Conclusions:
- CLP: Acute tox 4, H 302
- Executive summary:
Based on this study, the LD50 for ethyl phenols was determined to be 980.62 mg/kg bw. Mortality occurred in three of the four rats given the highest dose of 1750 mg/kg bw. Adverse clinical signs were observed at doses of 550 and 1750 mg/kg bw. A single dose of 175 mg/kg bw had no observable effect during the study.
Three rats in the 1750 mg/kg bw dose group were found dead during the study. Eight of the nine test animals showed dose related effects. There were no deaths in the 175 and 550 mg/kg bw dose groups. Clinical observations which were determined to be dose related included: lacrimation, excess salivation and urine stained fur in both the 550 and 1750 mg/kg bw dose groups. Decreased motor activity, twitches, prostrate, ptosis, limited use of hindlimbs, lost proprioceptive positioning, no use of both hind and forelimbs, ataxia, lost righting reflex, tachypnea, impaired righting reflex and scant faeces were observed in the 1750 mg/kg bw dose group. Necropsy confirmed the clinical observations. No gross lesions were found.
Body weight changes were reduced in the 550 and 1750 mg/kg bw dose groups compared to the rat in the 175 mg/kg bw dose group. However, all surviving rats gained weight after dose administration. Feed consumption values, both absolute (g/day) and relative (g/kg/day) showed a dose dependent reduction in the day after dosing in the 550 and 1750 mg/kg bw dose groups. This trend continued until day 5 post dosing, after which the values remaind comparative to the 175 mg/kg bw dosed animal.
Table 1: Mortality results of the up and down procedure with ethyl phenols
Step |
Dose (mg/kg bw) |
Response |
Include |
Log10 dose |
1 |
175 |
O |
No |
- |
2 |
550 |
O |
Yes |
2.740 |
3 |
1750 |
X |
Yes |
3.243 |
4 |
550 |
O |
Yes |
2.740 |
5 |
1750 |
X |
Yes |
3.243 |
6 |
550 |
O |
Yes |
2.740 |
7 |
1750 |
X |
Yes |
3.243 |
8 |
550 |
O |
No |
- |
9 |
1750 |
O |
No |
- |
Total |
17.949 |
|||
O = alive, X = dead
Sum of log10 doses/# of eligible rats: 17.949/6 = 2.9915, antilog of
2.9915 = 980.62 mg/kg bw = LD50
Table 2: Summary of observations of adverse effects during study
Observation |
175 mg/kg bw |
550 mg/kg bw |
1750 mg/kg bw |
Death |
0 |
0 |
3 |
Lacrimation |
0/0 |
1/1 |
4/4 |
Decreased motor activity |
0/0 |
0/0 |
4/4 |
Twitches |
0/0 |
0/0 |
3/3 |
Prostrate |
0/0 |
0/0 |
3/3 |
Excess salivation |
0/0 |
1/1 |
2/2 |
Ptosis |
0/0 |
0/0 |
2/2 |
Limited use of hindlimbs |
0/0 |
0/0 |
2/2 |
Lost proprioceptive positioning |
0/0 |
0/0 |
2/2 |
No use of both hind and forelimbs |
0/0 |
0/0 |
2/2 |
Ataxia |
0/0 |
0/0 |
2/2 |
Lost righting reflex |
0/0 |
0/0 |
2/2 |
Tachypnea |
0/0 |
0/0 |
2/2 |
Urine stained abdominal fur |
0/0 |
4/2 |
5/1 |
Impaired righting reflex |
0/0 |
0/0 |
1/1 |
Scant faeces |
0/0 |
0/0 |
1/1 |
Clear perinasal substance |
0/0 |
1/1 |
0/0 |
Chromorhinorrhea |
0/0 |
1/1 |
0/0 |
Maximum possible incidence |
14/1 |
56/4 |
17/4 |
Maximum possible incidence = (days x
rats)/number of rats examined per group
N/N = total number of observations/number of rats with observation
Table 3: Summary of body weight data
Rat body weight (g) |
175 mg/kg bw |
550 mg/kg bw |
1750 mg/kg bwa |
Day 1 |
203 ± 0.0 |
216.0 ± 14.4 |
225.8 ± 14.9 |
Day 2 |
219.0 ± 0.0 |
223.5 ± 22.7 |
229.0 ± 0.0 |
Day 3 |
216.0 ± 0.0 |
234.2 ± 19.5 |
220.0 ± 0.0 |
Day 4 |
227.0 ± 0.0 |
235.0 ± 19.1 |
234.0 ± 0.0 |
Day 5 |
228.0 ± 0.0 |
240.0 ± 22.4 |
246.0 ± 0.0 |
Day 6 |
233.0 ± 0.0 |
236.2 ± 19.0 |
254.0 ± 0.0 |
Day 7 |
241.0 ± 0.0 |
239.8 ± 21.4 |
258.0 ± 0.0 |
Day 8 |
239.0 ± 0.0 |
243.0 ± 25.1 |
255.0 ± 0.0 |
Day 9 |
241.0 ± 0.0 |
247.5 ± 24.6 |
262.0 ± 0.0 |
Day 10 |
246.0 ± 0.0 |
248.0 ± 22.2 |
262.0 ± 0.0 |
Day 11 |
261.0 ± 0.0 |
250.0 ± 18.8 |
268.0 ± 0.0 |
Day 12 |
254.0 ± 0.0 |
251.0 ± 17.6 |
272.0 ± 0.0 |
Day 13 |
263.0 ± 0.0 |
249.8 ± 24.0 |
279.0 ± 0.0 |
Day 14 |
263.0 ± 0.0 |
252.5 ± 24.0 |
276.0 ± 0.0 |
Mean ± SD
a= Excludes values for rats found dead.
Table 4: Summary of feed consumption data
Feed consumption (g/day) |
175 mg/kg bw |
550 mg/kg bw |
1750 mg/kg bwa |
Day 1-2 |
17.0 ± 0.0 |
11.8 ± 3.9 |
1.0 ± 0.0 |
Day 2-3 |
17.0 ± 0.0 |
19.8 ± 3.5 |
1.0 ± 0.0 |
Day 3-4 |
17.0 ± 0.0 |
18.5 ± 5.4 |
12.0 ± 0.0 |
Day 4-5 |
18.0 ± 0.0 |
17.7 ± 1.2 |
17.0 ± 0.0 |
Day 5-6 |
17.0 ± 0.0 |
18.0 ± 5.0 |
20.0 ± 0.0 |
Day 6-7 |
20.0 ± 0.0 |
20.5 ± 1.7 |
24.0 ± 0.0 |
Day 7-8 |
19.0 ± 0.0 |
19.2 ± 5.1 |
22.0 ± 0.0 |
Day 8-9 |
22.0 ± 0.0 |
19.2 ± 4.4 |
22.0 ± 0.0 |
Day 9-10 |
17.0 ± 0.0 |
21.5 ± 1.3 |
26.0 ± 0.0 |
Day 10-11 |
24.0 ± 0.0 |
19.0 ± 1.6 |
24.0 ± 0.0 |
Day 11-12 |
16.0 ± 0.0 |
20.5 ± 3.3 |
24.0 ± 0.0 |
Day 12-13 |
17.0 ± 0.0 |
18.5 ± 3.1 |
25.0 ± 0.0 |
Day 13-14 |
20.0 ± 0.0 |
18.2 ± 3.3 |
21.0 ± 0.0 |
Day 1-14 |
18.5 ± 0.0 |
18.7 ± 2.2 |
18.4 ± 0.0 |
Mean ± SD
a= Excludes values for rats found dead.
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: individual animal data not given
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Principles of method if other than guideline:
- 5 male rats/dose, observed for symptoms and mortality up to 10 - 14 days, afterwards gross autopsy
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- no further data
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- no further data
- Doses:
- 68, 100, 147, 215 mg/kg bw
- No. of animals per sex per dose:
- 5 male rats/dose
- Control animals:
- no
- Details on study design:
- no further details
- Statistics:
- yes, but method not mentioned
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 121 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 68 mg/kg bw: no deaths but signs of intoxication; recovery within 2 days
100 mg/kg bw: mortality: 2/5; survivors recovered within 4 days
147 mg/kg bw: mortality: 3/5; surviors recovered within 6 days
215 mg/kg bw: mortality: 5/5 - Clinical signs:
- other: All animals showed signs of intoxication including hypoactivity, tremor, convulsions, salivation, dyspnea, prostration within 4 hours post dosing
- Gross pathology:
- At autopsy, survivors showed no significant findings, decedents showed hemorrhage of gastrointestinal tract, hyperemia of liver, kidneys and lungs
- Other findings:
- no further data
- Interpretation of results:
- other: CLP/EU GHS Category 3 (H301) according to Regulation (EC) No 1272/2008
- Conclusions:
- CLP: Acute tox 3, H 301
- Executive summary:
To determine LD50-value 5 male rats/dose received single oral doses of 68, 100, 147, 215 mg/kg bw by gavage and were observed for symptoms and mortality for up to 10 - 14 days. Suvivors and decedents were examined afterwards by gross autopsy. LD50 was determined 121 mg/kg bw.
- Reason / purpose for cross-reference:
- read-across source
Reference
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- up-and-down procedure
- Limit test:
- no
- Species:
- rat
- Strain:
- other: Crl:CD(SD)IGS BR VAF/Plus
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories, Inc., Raleigh, North Carolina, USA
- Age at study initiation: 62 days (at arrival)
- Weight at study initiation: 198 - 217 g (on day after arrival)
- Fasting period before study: Fasted on the night before dosage administration, with feed returned to the animals folloing the 4 h clinical observation.
- Housing: Individually housed in stainless steel wire-bottomed cages.
- Diet (e.g. ad libitum): Certified Rodent Diet #5002 (PMI Nutrition International, Inc., St. Louis, Missouri, USA)
- Water (e.g. ad libitum): Local water, passed through a reverse osmosis membrane, available ad libitum, via automatic watering system.
- Acclimation period: 10 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 64 - 79°F (18 - 26°C)
- Humidity (%): 30 - 70%
- Air changes (per hr): Positive airflow, max. 10 changes per hour, HEPA filtered
- Photoperiod (hrs dark / hrs light): 12 h dark / 12 h light
IN-LIFE DATES: From: 01 March 2004 To: 25 March 2004 - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 35 mg/mL vehicle, 110 mg/mL vehicle, 350 mg/mL vehicle
- Amount of vehicle (if gavage): 5 mL/kg
- Justification for choice of vehicle: Not stated, guideline vehicle substance.
- Lot/batch no. (if required):
- Purity:
MAXIMUM DOSE VOLUME APPLIED: 5 mL/kg - Doses:
- 175, 550 and 1750 mg/kg bw
- No. of animals per sex per dose:
- All females, 1 rat for 175 mg/kg bw, 4 rats for 550 mg/kg bw and 4 rats for 1750 mg/kg bw
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Pre-dose, at least once in the 30 mins after dosage, at 30 mins, 60 mins, 2 h and 4 h and then daily thereafter for observations. Body weights were recorded weekly during acclimation, daily during the dosing and observation period and at sacrifice.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, feed consumption - Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 980.62 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Calculated from log 10 values.
- Sex:
- female
- Dose descriptor:
- other: NOEL
- Effect level:
- ca. 175 mg/kg bw
- Based on:
- other: Adverse clinical signs at 550 mg/kg bw
- Mortality:
- One rat in the 550 mg/kg bw dose group was sacrificed in a moribund condition, as were two rats in the 1750 mg/kg bw dose group. Two rats in the 1750 mg/kg bw dose group were found dead. These deaths were considered to be treatment related and adverse clinical signs were observed.
- Clinical signs:
- other: Clinical signs which were determined to be dose related were as follows. The rat sacrificed in the 550 mg/kg bw group displayed a hunched posture, gasping and scant faeces, it lost body weight and was sacrificed in a moribund condition. One rat in the 175
- Gross pathology:
- Persisitent clinical observations were confirmed at necropsy. No gross lesions were found.
- Other findings:
- Feed consumption, both absolute (g/day) and relative (g/kg bw/day) were reduced in the 550 mg/kg bw group compared to the 175 mg/kg bw dose group.
- Interpretation of results:
- other: CLP/EU GHS Category 4 (H302) according to Regulation (EC) No 1272/2008
- Conclusions:
- CLP: Acute tox 4, H 302
- Executive summary:
Based on this study, the LD50 for mixed xylenols was determined to be 980.62 mg/kg bw. Mortality occurred in three of the four rats given the highest dose of 1750 mg/kg. Adverse clinical signs were observed at doses of 550 and 1750 mg/kg. A single dose of 175 mg/kg had no observable effect during the study.
Mortality or moribundity occurred in one of four rats administered with 550 mg/kg bw and all four rats dosed with 1750 mg/kg bw of mixed xylenols. Adverse clinial signs were observed at doses of 550 and 1750 mg/kg bw. Clinical signs included: a hunched posture, gasping and scant faeces when dosed with 550 mg/kg bw and lost righting reflex, decreased motor activity, twitches, ptosis, lacrimation, ataxia, impaired righting reflex, lost proprioceptive positioning, prostrate, excess salivation, gasping and hyperpnea in the 1750 mg/kg bw dose group. Persisitent clinical observations were confirmed at necropsy. No gross lesions were found.
Body weight changes were reduced in the 550 mg/kg bw group compared to the rat in the 175 mg/kg bw group. Feed consumption, both absolute (g/day) and relative (g/kg bw/day) were reduced in the 550 mg/kg bw group compared to the 175 mg/kg bw dose group.
Table 1: Mortality results of the up and down procedure with mixed xylenols
Step |
Dose (mg/kg bw) |
Response |
Include |
Log10 dose |
1 |
175 |
O |
No |
- |
2 |
550 |
O |
Yes |
2.740 |
3 |
1750 |
X (MS) |
Yes |
3.243 |
4 |
550 |
X (MS) |
Yes |
2.740 |
5 |
1750 |
X (MS) |
Yes |
3.243 |
6 |
550 |
O |
Yes |
2.740 |
7 |
1750 |
X |
Yes |
3.243 |
8 |
550 |
O |
Yes |
2.740 |
9 |
1750 |
X |
Yes |
3.243 |
Total |
23.932 |
|||
O = alive, X = dead
Sum of log10 doses/# of eligible rats: 23.932/8 = 2.9915, antilog of
2.9915 = 980.62 mg/kg bw = LD50
Table 2: Summary of observations of adverse effects during study
Observation |
175 mg/kg bw |
550 mg/kg b w |
1750 mg/kg bw |
Mortality (found dead) |
0 |
0 |
2 |
Mortality (moribund sacrifice) |
0 |
1 |
2 |
Lost righting reflex |
0/0 |
0/0 |
4/4 |
Decreased motor activity |
0/0 |
0/0 |
4/4 |
Twitches |
0/0 |
0/0 |
4/4 |
Lacrimation |
0/0 |
0/0 |
4/4 |
Ptosis |
0/0 |
0/0 |
3/3 |
Ataxia |
0/0 |
2/2 |
2/2 |
Impaired righting reflex |
0/0 |
0/0 |
2/2 |
Gasping |
0/0 |
1/1 |
1/1 |
Lost proprioceptive positioning |
0/0 |
0/0 |
1/1 |
Prostrate |
0/0 |
0/0 |
1/1 |
Excess salivation |
0/0 |
0/0 |
1/1 |
Hyperpnea |
0/0 |
0/0 |
1/1 |
Hunched posture |
0/0 |
2/2 |
0/0 |
Scant faeces |
0/0 |
1/1 |
0/0 |
Maximum possible incidence |
14/1 |
45/4 |
5/4 |
Maximum possible incidence = (days x
rats)/number of rats examined per group
N/N = total number of observations/number of rats with observation
Table 3: Summary of body weight data
Rat body weight (g) |
175 mg/kg bw |
550 mg/kg bw |
1750 mg/kg bwa |
Day 1 |
209.0 ± 0.0 |
215.2 ± 14.2 |
218.5 ± 15.9 |
Day 2 |
224.0 ± 0.0 |
218.5 ± 12.6 |
- |
Day 3 |
228.0 ± 0.0 |
225.0 ± 16.8 |
- |
Day 4 |
228.0 ± 0.0 |
232.3 ± 17.8 |
- |
Day 5 |
239.0 ± 0.0 |
234.3 ± 22.8 |
- |
Day 6 |
238.0 ± 0.0 |
237.0 ± 25.6 |
- |
Day 7 |
241.0 ± 0.0 |
233.7 ± 26.8 |
- |
Day 8 |
248.0 ± 0.0 |
237.7 ± 25.2 |
- |
Day 9 |
246.0 ± 0.0 |
239.3 ± 22.5 |
- |
Day 10 |
252.0 ± 0.0 |
243.3 ± 18.2 |
- |
Day 11 |
255.0 ± 0.0 |
244.3 ± 25.1 |
- |
Day 12 |
260.0 ± 0.0 |
245.3 ± 26.4 |
- |
Day 13 |
260.0 ± 0.0 |
244.7 ± 25.8 |
- |
Day 14 |
262.0 ± 0.0 |
246.0 ± 27.9 |
- |
Mean ± SD
a= Excludes values for rats found dead.
Table 4: Summary of feed consumption data
Feed consumption (g/day) |
175 mg/kg bw |
550 mg/kg bw |
1750 mg/kg bwa |
Day 1-2 |
18.0 ± 0.0 |
11.3 ± 6.0 |
- |
Day 2-3 |
23.0 ± 0.0 |
16.8 ± 7.3 |
- |
Day 3-4 |
16.0 ± 0.0 |
16.3 ± 2.5 |
- |
Day 4-5 |
29.0 ± 0.0 |
19.0 ± 6.1 |
- |
Day 5-6 |
29.0 ± 0.0 |
18.7 ± 6.4 |
- |
Day 6-7 |
20.0 ± 0.0 |
16.7 ± 2.1 |
- |
Day 7-8 |
15.0 ± 0.0 |
19.3 ± 1.5 |
- |
Day 8-9 |
21.0 ± 0.0 |
16.0 ± 4.4 |
- |
Day 9-10 |
19.0 ± 0.0 |
19.0 ± 0.0 |
- |
Day 10-11 |
18.0 ± 0.0 |
19.7 ± 2.5 |
- |
Day 11-12 |
13.0 ± 0.0 |
17.3 ± 4.7 |
- |
Day 12-13 |
20.0 ± 0.0 |
18.7 ± 2.5 |
- |
Day 13-14 |
18.0 ± 0.0 |
17.0 ± 2.6 |
- |
Day 1-14 |
19.2 ± 0.0 |
17.9 ± 1.9 |
- |
Mean ± SD
a= Excludes values for rats found dead.
Data source
Materials and methods
Test material
- Reference substance name:
- Tar acids, xylenol fraction
- EC Number:
- 284-895-5
- EC Name:
- Tar acids, xylenol fraction
- Cas Number:
- 84989-06-0
- Molecular formula:
- not applicable
- IUPAC Name:
- 2,3-dimethylphenol; 2,4-dimethylphenol; 2,5-dimethylphenol; 2,6-dimethylphenol; 3,4-dimethylphenol; 3,5-dimethylphenol
Constituent 1
Results and discussion
Effect levels
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Remarks:
- rat
- Effect level:
- 121 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Source, CAS 95-48-7, o-cresol, IBTL, 1969
Any other information on results incl. tables
In the result table above the most critical value of the weight of evidence approach is given. In the following, the results are shown for the other source substances of this weight of evidence approach:
Source CAS 106 -44 -5: p-cresol: LD50 (male, rat) = 207 mg/kg bw (95% CL: >=172 <= 250); IBTL, 1969
Source CAS 108 -39 -4: m-cresol: LD50 (male, rat) = ca. 242 mg/kg bw (95% CL: >=190 <= 308); IBTL, 1969
Source mixed xylenols: LD50 (female, rat) = 980.62 mg/kg bw; Merisol, 2005
Source mixed ethylphenols: LD50 (female, rat) = 980.62 mg/kg bw; Merisol, 2005
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS Category 3 (H301) according to Regulation (EC) No 1272/2008
- Conclusions:
- Based on all available information (weight-of-evidence), following an analogue read-across approach and in the absence of data on acute oral toxicity of Tar acids, Xylenol fraction (CAS 84989-06-0), Tar acids, Xylenol fraction (CAS 84989-06-0) is classified for Acute oral toxicity (Cat. 3, H301) as a worst case.
- Executive summary:
Studies on mixed ethyl phenols and mixed xylenols resulted in a LD50 of 989.62 mg/kg bw. For the three cresol isomers the LD50 values were between 121 and 242 mg/kg bw. Thus, the cresol isomers seem to have a more toxic potential regarding acute oral toxicity than mixed ethyl phenols and mixed xylenols. However, as there are no acute oral toxicity data available for Tar acids, Xylenol fraction (CAS 84989-06-0) a worst-case approach was conducted taking into account all available data on the source substances and Tar acids, Xylenol fraction (CAS 84989-06-0) was therefore classified in Cat. 3 (H301) for acute oral toxicity according to Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
